stryker MAKO RESTORIS MCK BASEPLATE TRIAL (SIZE 5 RM/LL), REF 170615, intended for use in a Partial Knee Arthroplasty surgical procedure
FDA Recall Z-1385-2023 · Posted 2023-04-12
Advertisement
Recalling FirmHowmedica Osteonics Corp.
Recall StatusOpen, Classified
Product CodeHSX
Date Initiated2023-03-10
Product Quantity52 units
Reason for Recall
Ccertain lots of the Restoris MultiCompartmental Knee (MCK) Tibial Baseplate Trials contain product with incorrect size laser marking
Firm Action
Stryker issued an URGENT MEDICAL DEVICE RECALL notice to its consignees on 03/10/2023 by letter. The notice explained the issue and the hazard and requested the following actions be taken:
1. Please inform users of this Urgent Medical Device Recall and forward this notice to all individuals who need to be made aware.
2. Immediately check all stock areas and/or operating room storage to determine if any devices from the affected product list are at your facility.
3. Quarantine and discontinue use of the affected products in Table 1.
4. Complete and sign the enclosed Urgent Medical Device Recall Business Reply Form and email to [email protected]/ fax (888) 266-7910.
5. Please contact your Local Sales Office or your Stryker Sales Representative directly for product replacement and inventory questions.
6. Please return ALL affected product to: Stryker Orthopaedics/PFA Product Return.
Stryker issued an URGENT MEDICAL DEVICE RECALL UPDATE notice to its consignees on 04/12/2023. The letter contained the same information, but added a section titled Recommendations for patients already treated with an affected device, and advised patients treated with an affected product should continue to be followed per the normal protocol established by his or her surgeon(s).
Root Cause
Process change control
Distribution Pattern
U.S., Netherlands, Japan, China, India, Korea, and Australia.
Related FDA 510(k) Records
Devices referenced by this recall via K-numbers.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.
Advertisement